Penny stocks have always carried a mix of wild risk and outsized reward—and today’s tape is no different. From speculative biotech breakouts to beverage brands expanding their footprint, traders are chasing momentum across the sub-$5 space. Below, we break down five of the most talked-about penny stocks today—including Greene Concepts’ Be Water™, which just made a splash with a new international partnership.

1) Greene Concepts (OTC: INKW) — “Be Water™” Gets a Fresh Catalyst

Greene Concepts—owner of the Be Water™ premium bottled water brand—landed on traders’ radars this morning after announcing a collaboration with international capital strategist Dr. Rita Lustgarten aimed at accelerating growth and expanding clean-water access in the Middle East. For a thinly traded OTC name, any tangible distribution/partnership narrative can be a volume spark, and this update adds a real business-development angle to the Be Water story.

Why traders care: New partnership and ongoing expansion headlines can attract speculative flows in micro-caps, especially beverage/CPG names where distribution wins matter.

2) cbdMD (NYSE American: YCBD) — CBD Sympathy Momentum

Cannabis-linked tickers stayed lively after a video featuring President Trump advocating Medicare coverage for CBD circulated yesterday, which juiced sector sentiment into today. YCBD—a low-float CBD operator—often moves more than larger cannabis names when sector risk-on returns. Newsflow around cbdMD has also featured operational updates this year, giving it a “story + momentum” setup.

Why traders care: Sector-wide sentiment pop + penny-level liquidity can translate into outsized intraday moves.

3) Tilray Brands (Nasdaq: TLRY) — sub-$5 Cannabis Bellwether

TLRY remains the high-beta sector proxy under $5. It’s been swinging on the same CBD/rescheduling chatter driving YCBD, and it showed up on penny-stock leaderboards with strong volume in the last session. Policy hopes keep the tape jumpy—even while some outlets caution about fundamentals and regulatory timing.

Why traders care: Liquid, options-active name under $5 that often leads marijuana tape on headlines (and reversals).

4) Sunrise New Energy (Nasdaq: EPOW) — battery/EV Materials Angle

EPOW has been a repeated presence on daily penny leaderboards. A late-September PR about a U.S. 1GW lithium battery pack project (tied to its anode-materials business) helped put a fresh catalyst under the chart, keeping interest elevated into today’s session.

Why traders care: Anything touching EV supply chains can draw momentum screens; recent project news adds a tangible hook.

5) Plus Therapeutics (Nasdaq: PSTV) — Micro-cap Biotech With Insurance Milestone

Biotech PSTV has been perking up on headlines that UnitedHealthcare approved coverage for its CNSide® test (via subsidiary), plus recent upticks in news flow and watchlists. For micro-cap biotech, payer coverage is a meaningful validation that can sustain trader attention beyond a one-day pop.

Why traders care: Concrete commercial de-risking (payer coverage) + low float = momentum fuel.

How To Trade a Day Like This (Fast, Practical Notes)

• Focus on volume: Stick to names printing elevated, sustained volume (not just a one-minute spike). Lists like “Top 10 Penny Stocks” and day-gainer screens are a quick pulse check.
• Respect liquidity & slippage: OTCs (like INKW) can move on thin prints—size accordingly.
• Know your exit: These are trades, not endorsements. Pre-define stops and profit targets; don’t chase the third or fourth push.
• Beware the traps: Penny land remains ground zero for pump-and-dump risk—particularly in micro-/nano-floats and certain foreign micro-caps.

BE WATER DISCLAIMER Disclosure: Lusso’s News, LLC(“EMV”) has been compensated by Hemostemix Inc. (“Hemostemix”) in the amount of $5,000 USD per month, commencing August 13, 2025, and continuing through September 31, 2025, with the possibility of extension until further notice. This compensation is for the creation and dissemination of content about Hemostemix, including but not limited to articles, website postings, social media updates, and other promotional materials.
The content produced by EMV is intended solely for informational purposes. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any security, investment product, or trading strategy. EMV is not a registered investment adviser or broker-dealer, and nothing in this content should be construed as personalized investment advice.
Investing in securities involves risks, including the potential loss of principal. Readers should conduct their own independent research, perform due diligence, and consult with a licensed financial adviser, attorney, or tax professional before making any investment decisions.
EMV’s compensation from Hemostemix presents a conflict of interest as EMV has a financial incentive to promote Hemostemix. As a result, the content may be biased and should not be relied upon as independent or impartial.
By accessing this content or the associated website, you acknowledge and agree to the terms of this disclaimer.